A recent study has revealed that men afflicted with prostate cancer have a more than twice as likely chance of suffering a blood clot as compared to other males. The study took into consideration 76,000 Swedish men.

The study was conducted by a group of researchers at King’s College London. The lead researcher of the study was Mieke Van Hemelrijck. The findings of the study have been published in the journal Lancet Oncology.

It has been revealed that younger men who undertake hormone therapy for prostate cancer were at 2½ time greater risk to be afflicted with a deep-vein thrombosis (DVT). The risk of pulmonary embolism also doubled in such men.

It has been revealed that suffering from any type of cancer elevates the chance of developing a clot. These clots generally develop in the legs or lungs. The cause behind the development is uncertain.

However, this study is the foremost to evince the certain link between clotting and prostate cancer.

Mieke Van Hemelrijck, reveals, "Our findings indicate that it is important to consider thromboembolic side effects when treating patients with prostate cancer, especially those who require endocrine (hormonal) treatment".